Agilent initiated with bullish view at Wolfe Research, here’s why

As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Agilent with an Outperform rating and $140 price target, citing continued top-tier operational execution and solid management of Street expectations. The firm views the risk/reward as attractive despite broader concerns about headwinds in China and the biotech and pharmaceutical end market, the analyst tells investors.